These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 35370126

  • 1. Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
    Bor WL, de Veer AJW, Olie RH, Rikken SAOF, Chan Pin Yin DRPP, Herrman JPR, Vrolix M, Meuwissen M, Vandendriessche T, van Mieghem C, Magro M, Bennaghmouch N, Hermanides R, Adriaenssens T, Dewilde WJM, Ten Berg JM.
    EuroIntervention; 2022 Jul 22; 18(4):e303-e313. PubMed ID: 35370126
    [Abstract] [Full Text] [Related]

  • 2. Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial.
    Verburg A, Bor WL, Küçük IT, Henriques JPS, Vink MA, Ruifrok WT, Plomp J, Heestermans TACM, Schotborgh CE, Vlaar PJ, Magro M, Rikken SAOF, van den Broek WWA, van Mieghem CAG, Cornelis K, Rosseel L, Dujardin KS, Vandeloo B, Vandendriessche T, Ferdinande B, van 't Hof AWJ, Tijssen JGP, Limbruno U, De Caterina R, Rubboli A, Angiolillo DJ, Adriaenssens T, Dewilde W, Ten Berg JM.
    EuroIntervention; 2024 Jul 15; 20(14):e898-e904. PubMed ID: 39007830
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Fanaroff AC, Lopes RD.
    Prog Cardiovasc Dis; 2021 Jul 15; 69():11-17. PubMed ID: 34883097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation.
    Sammut MA, Conway D, Iqbal J, Krishnamurthy A, Morgan KP, Morris PD, Richardson JD, Rothman AMK, Gunn JP, Storey RF.
    Expert Rev Cardiovasc Ther; 2024 Jul 15; 22(7):339-345. PubMed ID: 38949642
    [Abstract] [Full Text] [Related]

  • 10. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A, Escamilla-Ocanas C, Dilip D, Saber H, Damani R.
    J Stroke Cerebrovasc Dis; 2021 Apr 15; 30(4):105654. PubMed ID: 33578352
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
    Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T, Vranckx P, Valgimigli M.
    Eur Heart J; 2019 Dec 07; 40(46):3757-3767. PubMed ID: 31651946
    [Abstract] [Full Text] [Related]

  • 12. Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.
    Andò G, Costa F.
    Int J Cardiol; 2020 Mar 01; 302():95-102. PubMed ID: 31924397
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Triska J, Haddadin F, Madanat L, Jabri A, Daher M, Birnbaum Y, Jneid H.
    Cardiovasc Drugs Ther; 2024 Jun 01; 38(3):605-619. PubMed ID: 35829979
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aspirin-omitted dual antithrombotic therapy in non-valvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis.
    Luo CF, Mo P, Li GQ, Liu SM.
    Eur Heart J Cardiovasc Pharmacother; 2021 May 23; 7(3):218-224. PubMed ID: 32129850
    [Abstract] [Full Text] [Related]

  • 17. Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.
    Berteotti M, Gori AM, Giusti B, Fortini A, Grossi G, Ciardetti N, Migliorini A, Lotti E, Valenti R, Di Mario C, Marchionni N, Marcucci R.
    J Thromb Thrombolysis; 2023 May 23; 55(4):667-679. PubMed ID: 36905562
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions.
    Zhou J, Wang X, Yu J, Wu Y, Li X, Xie X, Zhang X, Cheng D, Yang B.
    Clin Exp Pharmacol Physiol; 2023 Jul 23; 50(7):583-593. PubMed ID: 37057840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.